Cheryl Ho

21PUBLICATIONS
67CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyDeep learningCancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 26, 2026
Fusion of Clinical and Deep Learning Features for Predicting Pembrolizumab Monotherapy Response in Advanced Non-Small Cell Lung Cancer.

|Feb 21, 2025
Clinical Effectiveness and Cost-Effectiveness of Multigene Panel Sequencing in Advanced Melanoma: A Population-Level Real-World Target Trial Emulation.

Emanuel Krebs, Deirdre Weymann, Cheryl Ho

|Jan 25, 2025
Enhanced Lung Cancer Survival Prediction Using Semi-Supervised Pseudo-Labeling and Learning from Diverse PET/CT Datasets.

Mohammad R Salmanpour, Arman Gorji, Amin Mousavi

|Jan 24, 2025
A Canadian Perspective on Systemic Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma.

Anna Spreafico, Eric Winquist, Cheryl Ho

|Jan 11, 2025
Machine Learning and Computed Tomography Radiomics to Predict Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced Non-Small-Cell Lung Cancer: A Pilot Study.

Ian Janzen, Cheryl Ho, Barbara Melosky

|Dec 05, 2024
Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors.

Tharani Krishnan, Joao Paulo Solar Vasconcelos, Emma Titmuss

Pageof 4

Frequent Collaborators

6 joint publications

Barbara Melosky

5 joint publications

Bonnie Leung

4 joint publications

Aria Shokoohi

4 joint publications

Ren Yuan